Secondary Logo

Journal Logo

Articles by David A. Cooper

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

Koelsch, Kersten K.; Rasmussen, Thomas A.; Hey-Nguyen, William J.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(3):328-337, July 1st, 2017.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts

Madhavi, Vijaya; Kulkarni, Archana; Shete, Ashwini; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(3):345-353, July 1st, 2017.

Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings

Huis 't Veld, Diana; Balestre, Eric; Buyze, Jozefien; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(2):146-154, October 1st, 2015.

Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy

Haskelberg, Hila; Mallon, Patrick W.G.; Hoy, Jennifer; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2):161-168, October 1st, 2014.

Tuberculosis After Commencing Antiretroviral Therapy for HIV Infection Is Associated With Elevated CXCL9 and CXCL10 Responses to Mycobacterium tuberculosis Antigens

Oliver, Benjamin G.; Elliott, Julian H.; Price, Patricia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(3):287-292, November 1st, 2012.

A Randomized Study of Pharmacokinetics, Efficacy, and Safety of 2 Raltegravir Plus Atazanavir Strategies in ART-Treated Adults

Carey, Dianne; Pett, Sarah L.; Bloch, Mark; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2):143-149, June 1st, 2012.

Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy

Butler, Scott L.; Valdez, Hernan; Westby, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(3):297-303, November 1st, 2011.

The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection: Final Results From a Randomized Clinical Trial (Pulse)

Bloch, Mark T.; Smith, Don E.; Quan, Dick; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(2):192-202, June 2006.

Three-Year Durability of Dual-Nucleoside Versus Triple-Nucleoside Therapy in a Thai Population With HIV Infection

Ungsedhapand, Chaiwat; Srasuebkul, Preeyaporn; Cardiello, Peter; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(2):693-701, June 1st, 2004.

Pharmacokinetics of Indinavir/Ritonavir (800/100 mg) in Combination With Efavirenz (600 mg) in HIV-1-Infected Subjects

Boyd, Mark A.; Aarnoutse, Rob E.; Ruxrungtham, Kiat; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(2):134-139, October 1st, 2003.

Incubation and Duration of Specific Symptoms at Acute Retroviral Syndrome as Independent Predictors of Progression to AIDS

Vanhems, Philippe; Voirin, Nicolas; Hirschel, Bernard; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(5):542-544, April 15th, 2003.

Brief Report: Pharmacokinetics of Once-Daily Saquinavir Hard-Gelatin Capsules and Saquinavir Soft-Gelatin Capsules Boosted With Ritonavir in HIV-1-Infected Subjects

Cardiello, Peter G.; Monhaphol, Tarkika; Mahanontharit, Apicha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(4):375-379, April 1st, 2003.

Clinical Features of Acute Retroviral Syndrome Differ by Route of Infection but Not by Gender and Age

Vanhems, Philippe; Routy, Jean-Pierre; Hirschel, Bernard; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(3):318-321, November 1st, 2002.

Dose-Escalating Study of the Safety and Pharmacokinetics of Nelfinavir in HIV-Exposed Neonates

Rongkavilit, Chokechai; van Heeswijk, Rolf P. G.; Limpongsanurak, Sompop; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5):455-463, April 15th, 2002.

Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study

Cardiello, Peter G.; van Heeswijk, Rolf P.; Hassink, Elly A.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5):464-470, April 15th, 2002.

A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1-Infected Thai Patients

Ungsedhapand, Chaiwat; Kroon, Eugene D. M. B.; Suwanagool, Surapol; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(2):116-123, June 1st, 2001.

Impact of Early HIV-1 RNA and T-Lymphocyte Dynamics During Primary HIV-1 Infection on the Subsequent Course of HIV-1 RNA Levels and CD4+ T-Lymphocyte Counts in the First Year of HIV-1 Infection

Kaufmann, Gilbert R.; Cunningham, Philip; Zaunders, John; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(5):437-444, December 15th, 1999.

Comprehensive Classification of Symptoms and Signs Reported Among 218 Patients With Acute HIV-1 Infection

Vanhems, Philippe; Dassa, Clement; Lambert, Jean; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 21(2):99-106, June 1st, 1999.

Show: